Swiss National Bank’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Swiss National Bank’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,022	Closed	-$328K	–	2538
2018 Q1	$328K	Hold	5,022	–	–	﹤0.01%	2449
2017 Q4	$367K	Buy	5,022 +1,055	+27%	+$87.3K	﹤0.01%	2469
2017 Q3	$363K	Hold	3,967	–	–	﹤0.01%	2452
2017 Q2	$262K	Hold	3,967	–	–	﹤0.01%	2536
2017 Q1	$860K	Hold	3,967	–	–	﹤0.01%	2125
2016 Q4	$367K	Hold	3,967	–	–	﹤0.01%	2484
2016 Q3	$536K	Hold	3,967	–	–	﹤0.01%	2325
2016 Q2	$402K	Hold	3,967	–	–	﹤0.01%	2450
2016 Q1	$628K	Buy	3,967 +734	+23%	+$149K	﹤0.01%	2181
2015 Q4	$1.06M	Hold	3,233	–	–	﹤0.01%	1785
2015 Q3	$1.04M	Buy	3,233 +444	+16%	+$195K	﹤0.01%	1757
2015 Q2	$1.11M	Buy	2,789 +311	+13%	+$132K	﹤0.01%	1723
2015 Q1	$1.22M	Buy	2,478 +78	+3%	+$30.2K	﹤0.01%	1645
2014 Q4	$859K	Hold	2,400	–	–	﹤0.01%	1824
2014 Q3	$463K	Buy	2,400 +89	+4%	+$19.6K	﹤0.01%	2149
2014 Q2	$552K	Hold	2,311	–	–	﹤0.01%	2111
2014 Q1	$591K	Buy	2,311 +389	+20%	+$119K	﹤0.01%	2039
2013 Q4	$381K	Hold	1,922	–	–	﹤0.01%	2157
2013 Q3	$325K	Hold	1,922	–	–	﹤0.01%	2177
2013 Q2	$341K	Buy	+1,922	New	+$272K	﹤0.01%	2148

Other funds holding LUMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Swiss National Bank's LUMO Position: Q2 2018 in Review

Swiss National Bank sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2018, closing a stake of 5,022 shares — an estimated $328K sold.

Swiss National Bank first reported a position in LUMO in Q2 2013 and held it in 20 quarters. The position peaked at $1.22M in Q1 2015. 106 funds tracked by Wall St. Rank hold LUMO as of Q2 2018.

Swiss National Bank reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Swiss National Bank sold 5,022 Lumos Pharma, Inc. Common Stock shares in Q2 2018, an estimated $328K.
Swiss National Bank first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 20 quarters.
Swiss National Bank's Lumos Pharma, Inc. Common Stock position peaked at $1.22M in Q1 2015.
106 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2018.

Based on Swiss National Bank's 13F filing for Q2 2018, filed 9 Aug 2018.